{"id":"https://openalex.org/W7221151815","doi":"https://doi.org/10.3389/fonc.2026.1947593","title":"Tumor-antigen-specific polyclonal antibodies suppress tumor growth and metastasis in heterogeneous solid tumors","display_name":"Tumor-antigen-specific polyclonal antibodies suppress tumor growth and metastasis in heterogeneous solid tumors","publication_year":2026,"publication_date":"2026-10-09","ids":{"openalex":"https://openalex.org/W7221151815","doi":"https://doi.org/10.3389/fonc.2026.1947593","pmid":"https://pubmed.ncbi.nlm.nih.gov/42920539","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13690644"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2026.1947593","doi":"https://doi.org/10.3389/fonc.2026.1947593","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1947593","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1947593/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1947593/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081083805","display_name":"Carine Ciron","orcid":"https://orcid.org/0000-0002-2105-3094","observed_orcids":["https://orcid.org/0000-0002-2105-3094","https://orcid.org/0009-0002-8814-529X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carine Ciron","raw_affiliation_strings":["Xenothera"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenothera","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5094222528","display_name":"Oph\u00e9lie Dauphouy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4392021198","display_name":"Center for Research in Transplantation and Translational Immunology","ror":"https://ror.org/01165k395","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4392021198","https://openalex.org/I97188460"]},{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Oph\u00e9lie Dauphouy","raw_affiliation_strings":["Nantes Universit\u00e9, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), Center for Research in Transplantation and Translational Immunology (CR2TI)","Xenothera"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nantes Universit\u00e9, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), Center for Research in Transplantation and Translational Immunology (CR2TI)","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4392021198","https://openalex.org/I97188460"]},{"raw_affiliation_string":"Xenothera","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104262796","display_name":"Pierre Morice","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pierre Morice","raw_affiliation_strings":["Xenothera"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenothera","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087230323","display_name":"Pierre\u2010Joseph Royer","orcid":"https://orcid.org/0000-0001-5534-7982","observed_orcids":["https://orcid.org/0000-0001-5534-7982"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Pierre-Joseph Royer","raw_affiliation_strings":["Xenothera"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenothera","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105891957","display_name":"Gw\u00e9na\u00eblle Evanno","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gwena\u00eblle Evanno","raw_affiliation_strings":["Xenothera"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenothera","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054501659","display_name":"Juliette Rousse","orcid":"https://orcid.org/0000-0002-1418-0351","observed_orcids":["https://orcid.org/0000-0002-1418-0351"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juliette Rousse","raw_affiliation_strings":["Xenothera"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenothera","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032025022","display_name":"Fran\u00e7oise Shneiker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fran\u00e7oise Shneiker","raw_affiliation_strings":["Xenothera"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenothera","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080154745","display_name":"Bernard Vanhove","orcid":"https://orcid.org/0000-0002-2872-8648","observed_orcids":["https://orcid.org/0000-0002-2872-8648","https://orcid.org/0000-0001-7955-6842"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bernard Vanhove","raw_affiliation_strings":["Xenothera"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenothera","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076479407","display_name":"Odile Duvaux-Miret","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Odile Duvaux","raw_affiliation_strings":["Xenothera"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenothera","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047559299","display_name":"Firas Bassissi","orcid":"https://orcid.org/0000-0002-4319-0217","observed_orcids":["https://orcid.org/0000-0002-4319-0217"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Firas Bassissi","raw_affiliation_strings":["Xenothera"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenothera","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5087230323"],"corresponding_institution_ids":[],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.68866436,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":"1947593","last_page":"1947593"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9663000106811523,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9663000106811523,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.014000000432133675,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00860000029206276,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.7239999771118164},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.7480000257492065},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.5619999766349792},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.6520000100135803},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9039999842643738},{"id":"https://openalex.org/keywords/complement-activation","display_name":"complement activation","score":0.7139999866485596},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-phagocytosis","display_name":"antibody-dependent cellular phagocytosis","score":0.9459999799728394},{"id":"https://openalex.org/keywords/immunogenic-cell-death","display_name":"immunogenic cell death","score":0.828000009059906},{"id":"https://openalex.org/keywords/hmgb1","display_name":"HMGB1","score":0.9919999837875366},{"id":"https://openalex.org/keywords/slc3a2","display_name":"SLC3A2","score":0.9520000219345093},{"id":"https://openalex.org/keywords/annexin-a2","display_name":"annexin A2","score":0.8700000047683716},{"id":"https://openalex.org/keywords/ckap4","display_name":"CKAP4","score":0.9929999709129333},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.8289999961853027},{"id":"https://openalex.org/keywords/macrophage-polarization","display_name":"macrophage polarization","score":0.9200000166893005},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8690000176429749},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.7680000066757202}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6402999758720398},{"id":"https://openalex.org/C956191","wikidata":"https://www.wikidata.org/wiki/Q930144","display_name":"Polyclonal antibodies","level":3,"score":0.5856999754905701},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5853999853134155},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.545799970626831},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4934000074863434},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.427700012922287},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.38580000400543213},{"id":"https://openalex.org/C104397665","wikidata":"https://www.wikidata.org/wiki/Q860947","display_name":"Proteome","level":2,"score":0.375900000333786},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.36390000581741333},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3621000051498413},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.35989999771118164},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.35659998655319214},{"id":"https://openalex.org/C2780084626","wikidata":"https://www.wikidata.org/wiki/Q11793790","display_name":"Ovarian tumor","level":4,"score":0.35600000619888306},{"id":"https://openalex.org/C88634738","wikidata":"https://www.wikidata.org/wiki/Q24769543","display_name":"Annexin","level":3,"score":0.3481000065803528},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3449000120162964},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3237999975681305},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.32199999690055847},{"id":"https://openalex.org/C2780670749","wikidata":"https://www.wikidata.org/wiki/Q14908239","display_name":"Annexin A5","level":4,"score":0.3203999996185303},{"id":"https://openalex.org/C137738243","wikidata":"https://www.wikidata.org/wiki/Q189092","display_name":"Cell migration","level":3,"score":0.3027999997138977},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.29820001125335693},{"id":"https://openalex.org/C2777726029","wikidata":"https://www.wikidata.org/wiki/Q21114926","display_name":"Complement-dependent cytotoxicity","level":5,"score":0.2969000041484833},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.29280000925064087},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.28999999165534973},{"id":"https://openalex.org/C46111723","wikidata":"https://www.wikidata.org/wiki/Q471857","display_name":"Proteomics","level":3,"score":0.2879999876022339},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.2833000123500824},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.2777000069618225},{"id":"https://openalex.org/C97230052","wikidata":"https://www.wikidata.org/wiki/Q3854334","display_name":"Chorioallantoic membrane","level":3,"score":0.2759999930858612},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.275299996137619},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.27489998936653137},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.27469998598098755},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.27309998869895935},{"id":"https://openalex.org/C171196145","wikidata":"https://www.wikidata.org/wiki/Q4774577","display_name":"Antibody microarray","level":3,"score":0.27239999175071716},{"id":"https://openalex.org/C193270364","wikidata":"https://www.wikidata.org/wiki/Q17141925","display_name":"Tissue microarray","level":3,"score":0.26159998774528503},{"id":"https://openalex.org/C174510640","wikidata":"https://www.wikidata.org/wiki/Q489618","display_name":"HEK 293 cells","level":3,"score":0.25850000977516174},{"id":"https://openalex.org/C2775999222","wikidata":"https://www.wikidata.org/wiki/Q756289","display_name":"Wilms' tumor","level":2,"score":0.25699999928474426},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.250900000333786},{"id":"https://openalex.org/C30345302","wikidata":"https://www.wikidata.org/wiki/Q14908233","display_name":"Annexin A2","level":4,"score":0.25040000677108765}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2026.1947593","doi":"https://doi.org/10.3389/fonc.2026.1947593","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1947593","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1947593/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13690644","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13690644/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13690644/pdf/fonc-16-1947593.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:42920539","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42920539","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:0714e1dc3a2e4f8884fa7ae5cca95c73","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/0714e1dc3a2e4f8884fa7ae5cca95c73","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 16 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2026.1947593","doi":"https://doi.org/10.3389/fonc.2026.1947593","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1947593","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1947593/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7221151815.pdf","grobid_xml":"https://content.openalex.org/works/W7221151815.grobid-xml"},"referenced_works_count":46,"referenced_works":["https://openalex.org/W1823143396","https://openalex.org/W1991505853","https://openalex.org/W2103532601","https://openalex.org/W2252765364","https://openalex.org/W2441236057","https://openalex.org/W2536322725","https://openalex.org/W2599846384","https://openalex.org/W2607129810","https://openalex.org/W2619362292","https://openalex.org/W2767785958","https://openalex.org/W2913973491","https://openalex.org/W2977597545","https://openalex.org/W2995384862","https://openalex.org/W3042291772","https://openalex.org/W3104958039","https://openalex.org/W3127978879","https://openalex.org/W3212685780","https://openalex.org/W4214511313","https://openalex.org/W4220885717","https://openalex.org/W4307457915","https://openalex.org/W4313409784","https://openalex.org/W4321089153","https://openalex.org/W4378083369","https://openalex.org/W4379230146","https://openalex.org/W4387105742","https://openalex.org/W4387803115","https://openalex.org/W4389627021","https://openalex.org/W4390796639","https://openalex.org/W4392292026","https://openalex.org/W4394887517","https://openalex.org/W4395004912","https://openalex.org/W4396632251","https://openalex.org/W4396811295","https://openalex.org/W4398762379","https://openalex.org/W4399665403","https://openalex.org/W4399863227","https://openalex.org/W4402762635","https://openalex.org/W4403055783","https://openalex.org/W4404773644","https://openalex.org/W4404956337","https://openalex.org/W4408558833","https://openalex.org/W4409629792","https://openalex.org/W4409769271","https://openalex.org/W4410000970","https://openalex.org/W4410212054","https://openalex.org/W4414089778"],"related_works":["https://openalex.org/W4415940149","https://openalex.org/W4393096032","https://openalex.org/W4379333669","https://openalex.org/W4389627021","https://openalex.org/W4409643803","https://openalex.org/W2077517947","https://openalex.org/W1975842578","https://openalex.org/W2994454338","https://openalex.org/W4297215864","https://openalex.org/W2893126573"],"abstract_inverted_index":{"Introduction":[0],"Tumor":[1],"heterogeneity":[2],"and":[3,63,95,133,153,214,217,224,240,255],"signaling":[4],"redundancy":[5],"limit":[6],"the":[7,178,257],"efficacy":[8],"of":[9,21,45,54,170,182,192,201,266],"monospecific":[10],"antibody":[11],"therapies":[12],"in":[13,71,80,82,89,96,115,212,222],"solid":[14,267],"malignancies.":[15],"Here":[16],"we":[17],"used":[18],"our":[19],"platform":[20],"glyco-humanized":[22],"polyclonal":[23],"antibodies":[24],"(GH-pAb),":[25],"to":[26,176],"investigate":[27],"whether":[28],"targeting":[29,169],"multiple":[30],"tumor-associated":[31,161],"antigens":[32],"provides":[33],"integrated":[34],"anti-tumor":[35],"activity.":[36],"Methods":[37],"GH-pAb":[38],"(hereinafter":[39],"XON7)":[40],"were":[41,69],"generated":[42],"by":[43,65],"immunization":[44],"double-knockout":[46],"pigs":[47],"with":[48,234],"human":[49,60],"tumor":[50,127,210,238,253,258],"cells.":[51],"Antigen":[52],"specificity":[53],"XON7":[55,105,120,188,208,232,260],"was":[56,78,174],"assessed":[57],"using":[58],"a":[59,125,185,199,229,245],"proteome":[61],"array":[62],"validated":[64],"ELISA.":[66],"Anti-tumor":[67],"mechanisms":[68,265],"evaluated":[70],"vitro":[72],"on":[73],"2D":[74],"or":[75,84],"3D-cultures.":[76],"Efficacy":[77],"tested":[79],"vivo":[81,206],"cell":[83,203],"patient-derived":[85],"xenograft":[86],"(CDX,":[87],"PDX),":[88],"chicken":[90],"chorioallantoic":[91],"membrane":[92],"(CAM)":[93],"model,":[94,231],"orthotopic/metastatic":[97],"triple":[98],"negative":[99],"breast":[100],"cancer":[101],"(TNBC)":[102],"models.":[103,227],"Results":[104],"demonstrated":[106],"tumor-restricted":[107],"binding":[108],"across":[109,124],"tissue":[110],"microarrays":[111],"without":[112],"detectable":[113],"staining":[114],"matched":[116],"normal":[117],"tissues.":[118],"Mechanistically,":[119],"induced":[121,190],"potent":[122],"cytotoxicity":[123],"wide":[126],"panel":[128],"through":[129],"complement":[130],"activation,":[131],"apoptosis,":[132],"antibody-dependent":[134],"cellular":[135],"phagocytosis.":[136],"Proteome":[137],"profiling":[138],"identified":[139],"predominant":[140],"reactivities":[141],"against":[142],"solute":[143],"carrier":[144],"family":[145],"3":[146],"member":[147],"2":[148],"(SLC3A2),":[149],"annexin":[150],"A2":[151],"(ANXA2),":[152],"cytoskeleton-associated":[154],"protein":[155,195],"4":[156],"(CKAP4),":[157],"all":[158],"broadly":[159],"expressed":[160],"surface":[162],"proteins.":[163],"Immunodepletion":[164],"experiments":[165],"revealed":[166],"that":[167],"concurrent":[168],"these":[171],"three":[172],"targets":[173],"required":[175],"maintain":[177],"full":[179],"anti-proliferative":[180],"activity":[181],"XON7,":[183],"supporting":[184],"multitarget-dependent":[186],"mechanism.":[187],"also":[189],"released":[191],"high-mobility":[193],"group":[194],"box":[196],"1":[197],"(HMGB1),":[198],"hallmark":[200],"immunogenic":[202],"death.":[204],"In":[205,228],",":[207],"inhibited":[209],"growth":[211],"CDX":[213],"PDX":[215],"models,":[216],"markedly":[218],"reduced":[219],"metastatic":[220],"dissemination":[221],"orthotopic":[223],"intravenous":[225],"TNBC":[226],"CAM":[230],"synergized":[233],"PD-1":[235],"blockade,":[236],"enhancing":[237],"control":[239],"promoting":[241],"macrophage":[242],"polarization":[243],"toward":[244],"M1":[246],"phenotype.":[247],"Conclusion":[248],"By":[249],"simultaneously":[250],"engaging":[251],"non-redundant":[252],"pathways":[254],"reshaping":[256],"microenvironment,":[259],"may":[261],"overcome":[262],"key":[263],"resistance":[264],"tumors.":[268]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-10-10T00:00:00"}